Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.330
+0.080 (6.40%)
At close: Aug 13, 2025, 4:00 PM
1.300
-0.030 (-2.26%)
Pre-market: Aug 14, 2025, 9:18 AM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $11.01 million as of August 14, 2025. Its market cap has decreased by -62.81% in one year.
Market Cap
11.01M
Enterprise Value
20.67M
1-Year Change
-62.81%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $11.01M, a decrease of -60.71%. That is a compound annual growth rate of -5.10%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.91B |
| Johnson & Johnson | 418.57B |
| AbbVie | 354.34B |
| UnitedHealth Group | 244.46B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 223.79B |
| Novo Nordisk | 223.00B |